Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
N. Daver, G. Garcia-Manero, Sreyashi Basu, P. Boddu, M. Alfayez, J. Cortes, M. Konopleva, F. Ravandi-Kashani, E. Jabbour, T. Kadia, G. Nogueras-Gonzalez, J. Ning, N. Pemmaraju, C. Dinardo, M. Andreeff, S. Pierce, Tauna Gordon, S. Kornblau, W. Flores, Zainab Alhamal, C. Bueso-Ramos, J. Jorgensen, K. Patel, J. Blando, J. Allison, Padmanee Sharma, H. Kantarjian
Cancer Discovery